Teriflunomide is a medication used to treat multiple sclerosis (MS). It belongs to a class of drugs called immunomodulators, which work by suppressing the body's immune system to reduce inflammation and slow the progression of MS. Teriflunomide is usually taken once daily as a tablet. Common side effects include nausea, diarrhea, hair loss, and increased risk of infections.
Teriflunomide is a medication used to treat relapsing forms of multiple sclerosis (MS) [WebMD: Teriflunomide Oral]. Here's a breakdown of its key features:
Function:
- Teriflunomide is an immunomodulatory drug, meaning it affects the immune system [DrugBank: Teriflunomide].
- It's thought to work by decreasing the number of activated immune system cells (lymphocytes) that can attack the nerves in the brain and spinal cord in MS [WebMD: Teriflunomide Oral].
- This helps reduce the frequency and severity of MS flare-ups (relapses).
Administration:
- Taken orally, typically once a day [WebMD: Teriflunomide Oral].
Important Considerations:
- Teriflunomide doesn't cure MS, but it can help manage the symptoms [WebMD: Teriflunomide Oral].
- Not suitable for everyone: Due to its effects on the immune system, teriflunomide has potential side effects and may not be appropriate for people with certain medical conditions or who are pregnant or breastfeeding [WebMD: Teriflunomide Oral].
Potential Side Effects:
- Common side effects include: hair loss, nausea, diarrhea, and headache [WebMD: Teriflunomide Oral].
- More serious side effects, though uncommon, can occur and require immediate medical attention. These include: severe allergic reactions, liver problems, and infections due to weakened immune system [WebMD: Teriflunomide Oral].
Additional Information:
- Brand name: Aubagio® [WebMD: Teriflunomide Oral]
- It can take several months to experience the full benefits of teriflunomide [WebMD: Teriflunomide Oral].
- Due to potential complications stopping treatment, a special process is needed to eliminate teriflunomide from the body if necessary [WebMD: Teriflunomide Oral].
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AA Selective immunosuppressants
ATC Code
External Links
Teriflunomide